Literature DB >> 7481976

Herpes zoster and internal malignancy.

J B Smith1, N A Fenske.   

Abstract

Herpes zoster (HZ) often occurs concomitantly with various internal malignancies, most commonly hematologic in origin. Authors in the past proposed that HZ was a marker for internal malignancy, since it is often found in association with a malignancy. A critical review of the literature revealed that when HZ and malignancy occur in the same individual, rarely does HZ precede the malignancy, but usually follows it. Many studies have evaluated HZ in cancer patients, but only three studies have evaluated the occurrence of malignancy after the diagnosis of HZ, and all found no increased incidence of internal malignancy in patients with HZ. Since HZ is a poor marker for internal malignancy, extensive workups to find occult malignancy are not indicated. In rare cases, however, HZ precedes a malignancy. We therefore recommend a baseline history and physical examination, with further directed workup only if there are abnormal findings.

Entities:  

Mesh:

Year:  1995        PMID: 7481976     DOI: 10.1097/00007611-199511000-00001

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  11 in total

Review 1.  Regional pain syndromes in cancer patients.

Authors:  H A Zekry; E Bruera
Journal:  Curr Rev Pain       Date:  2000

2.  Is herpes zoster a marker for occult or subsequent malignancy?

Authors:  Frank Buntinx; Richard Wachana; Stefaan Bartholomeeusen; Kathleen Sweldens; Helena Geys
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

3.  Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans.

Authors:  Ralph P Insinga; Robbin F Itzler; James M Pellissier
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.

Authors:  Ronald R White; Greg Lenhart; Puneet K Singhal; Ralph P Insinga; Robbin F Itzler; James M Pellissier; Arthur W Segraves
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

5.  Risk of cancer among patients with herpes zoster infection: a population-based study.

Authors:  Yu-Ping Wang; Chia-Jen Liu; Yu-Wen Hu; Tzeng-Ji Chen; Yi-Tsung Lin; Chang-Phone Fung
Journal:  CMAJ       Date:  2012-09-17       Impact factor: 8.262

6.  Association between recent herpes zoster but not herpes simplex infection and subsequent risk of malignancy in women: a retrospective cohort study.

Authors:  F Buntinx; S Bartholomeeusen; A Belmans; C Mathei; G Opdenakker; K Sweldens; C Truyers; M Van Ranst
Journal:  Epidemiol Infect       Date:  2013-08-02       Impact factor: 4.434

7.  Herpes zoster and subsequent risk of cancer: a population-based study.

Authors:  Hui-Fen Chiu; Brian K Chen; Chun-Yuh Yang
Journal:  J Epidemiol       Date:  2013-04-01       Impact factor: 3.211

8.  Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in Taiwan.

Authors:  Yi-Chang Liu; Yi-Hsin Yang; Hui-Hua Hsiao; Wen-Chi Yang; Ta-Chih Liu; Chao-Sung Chang; Ming-Yu Yang; Pai-Mei Lin; Jui-Feng Hsu; Pi-Yu Chang; Sheng-Fung Lin
Journal:  BMC Cancer       Date:  2012-10-31       Impact factor: 4.430

9.  The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study.

Authors:  S J Cotton; J Belcher; P Rose; S K Jagadeesan; R D Neal
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

10.  The risk and prognosis of cancer after hospitalisation for herpes zoster: a population-based follow-up study.

Authors:  H T Sørensen; J H Olsen; P Jepsen; S P Johnsen; H C Schønheyder; L Mellemkjaer
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.